Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats

Brain Research

Volumn 1069, Issue 1, 2006, Pages 172-181

  Torregrossa, Mary M ^a,e   Jutkiewicz, Emily M ^a   Mosberg, Henry I ^b   Balboni, Gianfranco ^d   Watson, Stanley J ^a,c   Woods, James H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antidepressant; BDNF; Delta opioid receptor; Forced swim test; In situ hybridization; Peptide

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MESSENGER RNA; TYROSYLCYCLO[DEXTRO CYSTEINYLPHENYLALANYL DEXTRO PENICILLAMINE];

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; FORCED SWIMMING TEST; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADAMANTANE; ANIMALS; ANTIDEPRESSIVE AGENTS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DIPEPTIDES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; GENE EXPRESSION REGULATION; IMMOBILITY RESPONSE, TONIC; IN SITU HYBRIDIZATION; MALE; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RNA, MESSENGER; SWIMMING; TETRAHYDROISOQUINOLINES;

ANIMALIA; RODENTIA;

EID: 31344460390     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.11.005     Document Type: Article

References (37)

1. O. Aydemir, A. Deveci, and F. Taneli The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study Prog. Neuro-psychopharmacol. Biol. Psychiatry 29 2005 261 265
2. A. Baamonde, V. Dauge, M. Ruiz-Gayo, I.G. Fulga, S. Turcand, M.C. Fournie-Zaluski, and B.P. Roques Antidepressant-type effects of endogenous enkephalins protected by systemic RB101 are mediated by opioid delta and dopamine D1 receptor stimulation Eur. J. Pharmacol. 216 1992 157 166
3. G. Balboni, R. Guerrini, S. Salvadori, C. Bianchi, D. Rizzi, S.D. Bryant, and L.H. Lazarus Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties J. Med. Chem. 45 2002 713 720
4. D.C. Broom, J.F. Nitsche, J.E. Pintar, K.C. Rice, J.H. Woods, and J.R. Traynor Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice J. Pharmacol. Exp. Ther. 303 2002 723 729
5. D.C. Broom, E.M. Jutkiewicz, J.E. Folk, J.R. Traynor, K.C. Rice, and J.H. Woods Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats Neuropsychopharmacology 26 2002 744 755
6. D.C. Broom, E.M. Jutkiewicz, J.E. Folk, J.R. Traynor, K.C. Rice, and J.H. Woods Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant effects in Sprague-Dawley rats Psychopharmacology 164 2002 42 48
7. B. Chen, D. Dowlatshahi, G.M. MacQueen, J.-F. Wang, and L.T. Young Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication Biol. Psychiatry 50 2001 260 265
8. S.D. Comer, E.M. Hoenicke, A.I. Sable, R.W. McNutt, K.-J. Chang, B.R. DeCosta, H.I. Mosberg, and J.H. Woods Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice J. Pharmacol. Exp. Ther. 215 1993 127 134
9. A.L. Coppell, Q. Pei, and T.S.C. Zetterstrom Bi-phasic change in BDNF gene expression following antidepressant drug treatment Neuropharmacology 44 2003 903 910
10. G. DeFoubert, S.L. Carney, C.S. Robinson, E.J. Destexhe, R. Tomlinson, C.A. Hicks, T.K. Murray, J.P. Gaillard, C. Deville, V. Xhenseval, C.E. Thomas, M.J. O'Neill, and T.S.C. Zetterstrom Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment Neuroscience 128 2004 597 604
11. M.J. Detke, J. Johnson, and I. Lucki Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression Exp. Clin. Psychopharmacol. 5 1997 107 112
12. R.S. Duman Role of neurotrophic factors in the etiology and treatment of mood disorders Neuromol. Med. 5 2004 11 25
13. L.A. Dykstra, G.M. Shoenbaum, J. Yarbrough, R. McNutt, and K.-J. Chang A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration J. Pharmacol. Exp. Ther. 267 1993 875 882
14. G.L. Fraser, A.A. Pradhan, P.B.S. Clarke, and C. Wahlestedt Supraspinal antinociceptive response to [d-Pen2,5]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat J. Pharmacol. Exp. Ther. 295 2000 1135 1141
15. G.L. Fraser, H. Parenteau, T.-M. Tu, J. Ducharme, M.N. Perkins, and P.B.S. Clarke The effects of [delta] agonists on locomotor activity in habituated and non-habituated rats Life Sci. 67 2000 913 922
16. J. Haffmans, and M.R. Dzoljic Differential epileptogenic potentials of selective mu and delta opiate receptor agonists J. Neural Transm. 57 1983 1 11
17. D.L. Heyl, J.R. Omnaas, K. Sobczyk-Kojiro, F. Medzihradsky, C.B. Smith, and H.I. Mosberg Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue and carboxy terminal residue variation in a cyclic disulfide-containing opioid tetrapeptide Int. J. Pept. Protein Res. 37 1991 224 229
18. E.J. Hong, K.C. Rice, S. Calderon, J.H. Woods, and J.R. Traynor Convulsive behavior of nonpeptide delta opioid ligands: comparison of SNC80 and BW373U86 in mice Analgesia 3 1998 269 276
19. P.J. Isackson, M.M. Huntsman, K.D. Murray, and C.M. Gall BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF Neuron 6 1991 937 948
20. E.M. Jutkiewicz, E.B. Eller, J.E. Folk, K.C. Rice, J.R. Traynor, and J.H. Woods Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats J. Pharmacol. Exp. Ther. 309 2004 173 181
21. E.M. Jutkiewicz, N.P. Walker, J.E. Folk, K.C. Rice, P.S. Portoghese, J.H. Woods, and J.R. Traynor Comparison of peptide and nonpeptidic delta-opioid agonists on [35S]GTPgammaS binding in brain slices from Sprague-Dawley rats J. Pharmacol. Exp. Ther. 312 2005 1314 1320
22. E.M. Jutkiewicz, K.C. Rice, J.R. Traynor, and J.H. Woods Separation of the convulsions and antidepressant-like effects produced by the delta opioid receptor agonist SNC80 in rats Psychopharmacology 182 2005 588 596
23. Jutkiewicz, E.M., Torregrossa, M.M., Sobczyk-Kojiro, K., Mosberg, H.I., Folk, J.E., Rice, K.C., Watson, S.J., Woods, J.H., submitted for publication. Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. Eur. J. Pharmacol.
24. N. Kobori, G.L. Clifton, and P.K. Dash Altered expression of novel genes in the cerebral cortex following experimental brain injury Mol. Brain Res. 104 2002 148 158
25. X. Miro, S. Perez-Torres, F. Artigas, P. Puigdomenech, J.M. Palacios, and G. Mengod Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment, an in situ hybridization study Neuropharmacology 43 2002 1148 1157
26. S.S. Negus, E.R. Butelman, K.J. Chang, B. DeCosta, G. Winger, and J.H. Woods Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys J. Pharmacol. Exp. Ther. 270 1994 1025 1034
27. M. Nibuya, S. Morinobu, and R.S. Duman Regulation of BDNF and TrkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J. Neurosci. 15 1995 7539 7547
28. M. Nibuya, E.J. Nestler, and R.S. Duman Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus J. Neurosci. 16 1996 2365 2372
29. E.D. Pakarinen, J.H. Woods, and J.M. Moerschbaecher Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa, and delta opioid agonist J. Pharmacol. Exp. Ther. 272 1995 552 559
30. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 2nd ed. 1986 Academic Press San Diego
31. A. Saitoh, Y. Kimura, T. Suzuki, K. Kawai, H. Nagase, and J. Kamei Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents J. Pharmacol. Sci. 95 2004 374 380
32. Y. Shirayama, A.C.-H. Chen, S. Nakagawa, D.S. Russell, and R.S. Duman Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression J. Neurosci. 22 2002 3251 3261
33. J.A. Siuciak, D.R. Lewis, S.J. Wiegand, and R.M. Lindsay Antidepressant-like effect of brain-derived neurotrophic factor (BDNF) Pharmacol. Biochem. Behav. 56 1997 131 137
34. P. Tejedor-Real, J.A. Mico, C. Smadja, R. Maldonado, B.P. Roques, and J. Gibert-Rahola Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model Eur. J. Pharmacol. 354 1998 1 7
35. M.M. Torregrossa, C. Isgor, J.E. Folk, K.C. Rice, S.J. Watson, and J.H. Woods The delta opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats Neuropsychopharmacology 29 2004 649 659
36. M.M. Torregrossa, J.E. Folk, K.C. Rice, S.J. Watson, and J.H. Woods Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats Psychopharmacology 183 2005 31 40
37. H.N. Zhang, J.H. Woods, S.J. Watson, and M.C. Ko Antidepressant-like effects of endogenous opioid peptides in rats: behavioral and BDNF mRNA expression studies FASEB J. 19 2005 A1542 A1543